CRDL logo

Cardiol Therapeutics Inc. (CRDL)

Profile

Full Name

Cardiol Therapeutics Inc.

Ticker

NASDAQ: CRDL

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

Canada

IPO

January 15, 2019

Indexes

Not included

Website

https://www.cardiolrx.com

Employees

18

Key Details

Price

$1.05(9.22%)

Market Cap

$105.00M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$0.37(-15.71% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.05
    CRDL price is $1.05

    30-Day Relative Volume

    1.37
    CRDL 30-day relative volume is 1.37

    Price Performance

    Price 1-Day Change

    +9.22%
    CRDL price is up +9.22% today

    Price YTD Change

    -17.97%
    CRDL price is down -17.97% since January 1st

    Price 1-Year Change

    -27.08%
    CRDL price is down -27.08% year-on-year

    Price 3-Year Change

    +104.68%
    CRDL price is up +104.68% over the past 3 years

    Price Range

    Price All-Time High

    $10.00
    CRDL price is currently -89.50% below its historical high of $10.00

    Price 3-Year Low

    $0.45
    CRDL price is currently +133.33% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $105.00M
    CRDL market cap is $105.00 million

    Market Cap 3-Year Change

    +221.29%
    CRDL market cap is up +221.29% over the past 3 years

    Market Cap All-Time High

    $213.88M
    CRDL market cap is currently -50.91% below its historical high of $213.88 million

    Market Cap Sector Percentile

    41.76%
    CRDL market cap is higher than 41.76% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +22.54%
    CRDL shares outstanding is up +22.54% year-on-year

    Shares Outstanding 3-Year Change

    +56.97%
    CRDL shares outstanding is up +56.97% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.32
    CRDL beta is 1.32

    200-day SMA

    $1.15
    CRDL price is currently -8.53% below its 200-day simple moving average

    50-day SMA

    $1.06
    CRDL price is currently -0.93% below its 50-day simple moving average

    14-Day RSI

    53.37
    CRDL 14-day relative strength index is 53.37

    Volume

    1.37
    CRDL 30-day relative volume is 1.37

    ATR

    $0.08
    CRDL average true range is $0.08

    10-day Historical Volatility

    75.98%
    CRDL 10-day historical volatility is 75.98%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    CRDL annual revenue is $0.00

    Revenue Analysts Estimate

    -
    CRDL annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    CRDL annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.27%
    CRDL annual revenue is higher than 28.27% of companies in Healthcare sector

    EPS

    EPS

    -$0.37
    CRDL annual earnings per share is -$0.37

    EPS Analysts Estimate

    -$0.43
    CRDL annual earnings per share is currently +13.00% higher than the consensus analysts' forecast

    EPS 1-Year Change

    -15.71%
    CRDL annual earnings per share is down -15.71% year-on-year

    EPS Sector Percentile

    70.92%
    CRDL annual earnings per share is higher than 70.92% of companies in Healthcare sector

    Profit

    Gross Profit

    -$272.40K
    CRDL annual gross profit is -$272.40 thousand

    Gross Margin

    -
    CRDL annual gross profit margin value is unknown

    Operating Profit

    -$29.38M
    CRDL annual operating income is -$29.38 million

    Operating Margin

    -
    CRDL annual operating profit margin value is unknown

    Net Income

    -$26.77M
    CRDL annual net profit is -$26.77 million

    Net Margin

    -
    CRDL annual net profit margin value is unknown

    Expenses

    Total Expenses

    $29.38M
    CRDL annual total expenses is $29.38 million

    Operating Expenses

    $29.38M
    CRDL annual total operating expenses is $29.38 million

    Cost Of Goods Sold

    $272.40K
    CRDL annual cost of goods sold is $272.40 thousand

    Selling, General & Administrative Expenses

    $19.16M
    CRDL annual SG&A is $19.16 million

    Depreciation & Amortization

    $272.20K
    CRDL annual D&A is $272.20 thousand

    Interest Expense

    $0.00
    CRDL annual interest expense is $0.00

    Income Tax

    $0.00
    CRDL annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$29.38M
    CRDL annual earnings before interest & taxes is -$29.38 million

    EBITDA

    -$29.11M
    CRDL annual EBITDA is -$29.11 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $22.16M
    CRDL annual total assets is $22.16 million

    Non Current Assets

    $136.30K
    CRDL annual long term assets is $136.30 thousand

    Current Assets

    $22.07M
    CRDL annual total current assets is $22.07 million

    Cash and Cash Equivalents

    $21.31M
    CRDL annual cash & cash equivalents is $21.31 million

    Accounts Receivable

    $69.80K
    CRDL annual accounts receivable is $69.80 thousand

    Inventory

    $0.00
    CRDL annual inventory is $0.00

    Liabilities

    Total Liabilities

    $4.96M
    CRDL annual total liabilities is $4.96 million

    Long Term Liabilities

    $87.50K
    CRDL annual total long term liabilities is $87.50 thousand

    Current Liabilities

    $4.88M
    CRDL annual current liabilities is $4.88 million

    Accounts Payable

    $0.00
    CRDL annual accounts payable is $0.00

    Debt

    Total Debt

    $110.20K
    CRDL annual total debt is $110.20 thousand

    Total Debt 1-Year Change

    -16.64%
    CRDL annual total debt is down -16.64% year-on-year

    Long Term Debt

    $87.50K
    CRDL annual long term debt is $87.50 thousand

    Short Term Debt

    $23.00K
    CRDL annual short term debt is $23.00 thousand

    Equity & Capital

    Shareholders Equity

    $17.19M
    CRDL annual stockholders equity is $17.19 million

    Book Value

    $17.23M
    CRDL annual book value is $17.23 million

    Retained Earnings

    -$124.90M
    CRDL annual retained earnings is -$124.90 million

    Working Capital

    $17.15M
    CRDL annual working capital is $17.15 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$18.28M
    CRDL annual cash from operations is -$18.28 million

    Cash From Operations 1-Year Change

    +1.97%
    CRDL annual cash from operations is up +1.97% year-on-year

    Cash From Investing

    -$15.50K
    CRDL annual cash from investing is -$15.50 thousand

    Cash From Investing 1-Year Change

    +67.44%
    CRDL annual cash from investing is up +67.44% year-on-year

    Cash From Financing

    $13.74M
    CRDL annual cash from financing is $13.74 million

    Cash From Financing 1-Year Change

    +33621.95%
    CRDL annual cash from financing is up +33621.95% year-on-year

    CAPEX

    CAPEX

    $15.50K
    CRDL annual capital expenditures is $15.50 thousand

    CAPEX 1-Year Change

    -67.44%
    CRDL annual capital expenditures is down -67.44% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$18.30M
    CRDL annual free cash flow is -$18.30 million

    Free Cash Flow 1-Year Change

    +2.13%
    CRDL annual free cash flow is up +2.13% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    CRDL annual gross profit margin value is unknown

    Operating Margin

    -
    CRDL annual operating profit margin value is unknown

    Net Margin

    -
    CRDL annual net profit margin value is unknown

    ROA & ROE

    ROA

    -107.12%
    CRDL annual return on assets is -107.12%

    ROE

    -138.66%
    CRDL annual return on equity is -138.66%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    CRDL price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    CRDL price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    15.28
    CRDL price to book ratio is 15.28

    PB Ratio Sector Percentile

    91.75%
    CRDL price to book ratio is higher than 91.75% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    CRDL price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    CRDL price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $96.74M
    CRDL enterprise value is $96.74 million

    Enterprise Value Sector Percentile

    43.95%
    CRDL enterprise value is higher than 43.95% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.74
    CRDL EV/EBITDA is -3.74

    EV/EBITDA Sector Percentile

    29.54%
    CRDL EV/EBITDA is higher than 29.54% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    4.52
    CRDL annual current ratio is 4.52

    Quick Ratio

    4.52
    CRDL annual quick ratio is 4.52

    Leverage

    Debt To Equity

    0.01
    CRDL annual debt to equity ratio is 0.01

    Interest Coverage Ratio

    -
    CRDL annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    CRDL piotroski f-score value is unknown

    Altman Z-Score

    1.36
    CRDL altman z-score is 1.36

    Analyst ratings

    Recent major analysts updates

    Jun 2, 25 HC Wainwright & Co.
    Buy
    Apr 16, 25 HC Wainwright & Co.
    Buy
    Apr 7, 25 HC Wainwright & Co.
    Buy
    Feb 24, 25 HC Wainwright & Co.
    Buy
    Dec 18, 24 HC Wainwright & Co.
    Buy
    Nov 20, 24 HC Wainwright & Co.
    Buy
    Oct 24, 24 HC Wainwright & Co.
    Buy
    Jun 26, 24 Roth MKM
    Buy
    Jun 14, 24 HC Wainwright & Co.
    Buy
    Jun 7, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with CRDL included

    Growing Shares Outstanding
    Stocks with high beta
    Stocks below SMA 200
    NASDAQ Dividend Calendar
    Canadian stocks
    Stocks above SMA 50
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    NASDAQ Listed Companies
    • What is the ticker symbol for Cardiol Therapeutics Inc.?
    • Does Cardiol Therapeutics Inc. pay dividends?
    • What sector is Cardiol Therapeutics Inc. in?
    • What industry is Cardiol Therapeutics Inc. in?
    • What country is Cardiol Therapeutics Inc. based in?
    • When did Cardiol Therapeutics Inc. go public?
    • Is Cardiol Therapeutics Inc. in the S&P 500?
    • Is Cardiol Therapeutics Inc. in the NASDAQ 100?
    • Is Cardiol Therapeutics Inc. in the Dow Jones?
    • When was Cardiol Therapeutics Inc.'s last earnings report?
    • When does Cardiol Therapeutics Inc. report earnings?

    What is the ticker symbol for Cardiol Therapeutics Inc.?

    The ticker symbol for Cardiol Therapeutics Inc. is NASDAQ:CRDL

    Does Cardiol Therapeutics Inc. pay dividends?

    No, Cardiol Therapeutics Inc. does not pay dividends

    What sector is Cardiol Therapeutics Inc. in?

    Cardiol Therapeutics Inc. is in the Healthcare sector

    What industry is Cardiol Therapeutics Inc. in?

    Cardiol Therapeutics Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is Cardiol Therapeutics Inc. based in?

    Cardiol Therapeutics Inc. is headquartered in Canada

    When did Cardiol Therapeutics Inc. go public?

    Cardiol Therapeutics Inc.'s initial public offering (IPO) was on January 15, 2019

    Is Cardiol Therapeutics Inc. in the S&P 500?

    No, Cardiol Therapeutics Inc. is not included in the S&P 500 index

    Is Cardiol Therapeutics Inc. in the NASDAQ 100?

    No, Cardiol Therapeutics Inc. is not included in the NASDAQ 100 index

    Is Cardiol Therapeutics Inc. in the Dow Jones?

    No, Cardiol Therapeutics Inc. is not included in the Dow Jones index

    When was Cardiol Therapeutics Inc.'s last earnings report?

    Cardiol Therapeutics Inc.'s most recent earnings report was on March 28, 2024

    When does Cardiol Therapeutics Inc. report earnings?

    The date for Cardiol Therapeutics Inc.'s next earnings report has not been announced yet
    On this page